WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Earnings & Revenue

CTMX past revenue growth

How has CTMX's revenue growth performed historically?
Company
90.38%
Industry
165.61%
Market
17.84%
CTMX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTMX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CTMX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CTMX earnings and revenue history

Current Revenue
$101.2M
Current Earnings
-$569.0k
Current Profit Margin
-0.6%

CTMX Return on Equity

Current Company
N/A
Current Industry
-63.6%
Current Market
188%

Be the first to know when CTMX announces earnings.

CTMX Return on Assets

Current Company
-0.3%
Current Industry
3%
CTMX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTMX Return on Capital Employed

Current Company
7.24%
Current Industry
19.6%
CTMX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTMX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTMX$101.21M$9.23M-$569.00k+11.21%N/A
GALT$0.00-$43.04M-$45.44MN/AN/A
CLLS$24.41M-$27.35M-$85.01M-0.84%N/A
NVCT$0.00-$22.26M-$22.26MN/AN/A
PDSB$0.00-$42.87M-$42.94MN/AN/A

CTMX earnings dates

Next earnings date
May 7, 2024

Cytomx Therapeutics Earnings & Revenue FAQ

What were CTMX's earnings last quarter?

On Invalid Date, Cytomx Therapeutics (NASDAQ: CTMX) reported Q4 2023 earnings per share (EPS) of $0.01, up 107.69% year over year. Total Cytomx Therapeutics earnings for the quarter were $837.00 thousand. In the same quarter last year, Cytomx Therapeutics's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.

What was CTMX's earnings growth in the past year?

As of Q1 2024, Cytomx Therapeutics's earnings has grown year over year. Cytomx Therapeutics's earnings in the past year totalled -$569.00 thousand.

What is CTMX's earnings date?

Cytomx Therapeutics's earnings date is Invalid Date. Add CTMX to your watchlist to be reminded of CTMX's next earnings announcement.

What was CTMX's revenue last quarter?

On Invalid Date, Cytomx Therapeutics (NASDAQ: CTMX) reported Q4 2023 revenue of $26.61 million up 32.22% year over year. In the same quarter last year, Cytomx Therapeutics's revenue was $20.12 million.

What was CTMX's revenue growth in the past year?

As of Q1 2024, Cytomx Therapeutics's revenue has grown 90.38% year over year. This is 75.23 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Cytomx Therapeutics's revenue in the past year totalled $101.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.